# RAS Blockade at Bedtime Versus on Awakening for Aldosterone Breakthrough

> **NCT01805362** · NA · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Nice** · enrollment: 104 (actual)

## Conditions studied

- Chronic Kidney Disease

## Interventions

- **OTHER:** Randomization that determine the time of treatment

## Key facts

- **NCT ID:** NCT01805362
- **Lead sponsor:** Centre Hospitalier Universitaire de Nice
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02-27
- **Primary completion:** 2014-04-24
- **Final completion:** 2018-01-12
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2024-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01805362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01805362, "RAS Blockade at Bedtime Versus on Awakening for Aldosterone Breakthrough". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01805362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*